Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6523394 | 7234932 | I | 6523394-X | 20091223 | 20091231 | EXP | FR-ROCHE-676511 | ROCHE | 78 | YR | M | Y | 40 | KG | 20091231 | MD | FRANCE |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6523394 | 1012885623 | PS | XELODA | 1 | ORAL | 020896 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6523394 | 1012885623 | PANCREATIC CARCINOMA METASTATIC |
Outcome of event
Event ID | OUTC COD |
---|---|
6523394 | OT |
Reactions reported
Event ID | PT |
---|---|
6523394 | MELANODERMIA |
6523394 | OPTIC ATROPHY |
6523394 | OPTIC NEURITIS |
6523394 | VISUAL ACUITY REDUCED |
6523394 | VISUAL EVOKED POTENTIALS ABNORMAL |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
6523394 | 1012885623 | 20080701 |